-
1دورية أكاديمية
المؤلفون: Geyer, CE, Garber, JE, Gelber, RD, Yothers, G, Taboada, M, Ross, L, Rastogi, P, Cui, K, Arahmani, A, Aktan, G, Armstrong, AC, Arnedos, M, Balmana, J, Bergh, J, Bliss, J, Delaloge, S, Domchek, SM, Eisen, A, Elsafy, F, Fein, LE, Fielding, A, Ford, JM, Friedman, S, Gelmon, KA, Gianni, L, Gnant, M, Hollingsworth, SJ, Im, SA, Jager, A, Lakhani, SR, Janni, W, Linderholm, B, Liu, TW, Loman, N, Korde, L, Loibl, S, Lucas, PC, Marme, F, de Duenas, EM, McConnell, R, Phillips, KA, Piccart, M, Rossi, G, Schmutzler, R, Senkus, E, Shao, Z, Sharma, P, Singer, CF, Spanic, T, Stickeler, E, Toi, M, Traina, TA, Viale, G, Zoppoli, G, Park, YH, Yerushalmi, R, Yang, H, Pang, D, Jung, KH, Mailliez, A, Fan, Z, Tennevet, I, Zhang, J, Nagy, T, Sonke, GS, Sun, Q, Parton, M, Colleoni, MA, Schmidt, M, Brufsky, AM, Razaq, W, Kaufman, B, Cameron, D, Campbell, C, Tutt, ANJ, Johannsson, OT
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 33(12):1250-1268
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Jhaveri, K, Eli, LD, Wildiers, H, Hurvitz, SA, Guerrero-Zotano, A, Unni, N, Brufsky, A, Park, H, Waisman, J, Yang, ES, Spanggaard, I, Reid, S, Burkard, ME, Vinayak, S, Prat, A, Arnedos, M, Bidard, F-C, Loi, S, Crown, J, Bhave, M, Piha-Paul, SA, Suga, JM, Chia, S, Saura, C, Garcia-Saenz, JÁ, Gambardella, V, de Miguel, MJ, Gal-Yam, EN, Rapael, A, Stemmer, SM, Ma, C, Hanker, AB, Ye, D, Goldman, JW, Bose, R, Peterson, L, Bell, JSK, Frazier, A, DiPrimeo, D, Wong, A, Arteaga, CL, Solit, DB
العلاقة: pii: S0923-7534(23)00800-1; Jhaveri, K., Eli, L. D., Wildiers, H., Hurvitz, S. A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E. S., Spanggaard, I., Reid, S., Burkard, M. E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F. -C., Loi, S., Crown, J. ,. Solit, D. B. (2023). Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial. Ann Oncol, 34 (10), pp.885-898. https://doi.org/10.1016/j.annonc.2023.08.003Test.; http://hdl.handle.net/11343/337281Test
-
3دورية أكاديمية
المؤلفون: Jhaveri, K., Eli, L.D., Wildiers, H., Hurvitz, S.A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E.S., Spanggaard, I., Reid, S., Burkard, M.E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F.-C., Loi, S., Crown, J., Bhave, M., Piha-Paul, S.A., Suga, J.M., Chia, S., Saura, C., Garcia-Saenz, J.Á., Gambardella, V., de Miguel, M.J., Gal-Yam, E.N., Raphael, A., Stemmer, S.M., Ma, C., Hanker, A.B., Ye, D., Goldman, J.W., Bose, R., Peterson, L., Bell, J.S.K., Frazier, A., DiPrimeo, D., Wong, A., Arteaga, C.L., Solit, D.B.
المساهمون: Breast Cancer Research Foundation, Memorial Sloan-Kettering Cancer Center, Puma Biotechnology, National Cancer Institute
المصدر: Annals of Oncology ; volume 34, issue 10, page 885-898 ; ISSN 0923-7534
الإتاحة: https://doi.org/10.1016/j.annonc.2023.08.003Test
https://api.elsevier.com/content/article/PII:S0923753423008001?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753423008001?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: Vuduc, L., Jacot, W., Frenel, J-S., Brain, E.G.C., Dieras, V.C., Bachelot, T., Mailliez, A., Dalenc, F., Cottu, P.H., Arnedos, M., Lefeuvre-Plesse, C., Gonçalves, A., Grinda, T., Antoine, A., Chevrot, M., Perol, D., Cournede, P-H., Delaloge, S.
المصدر: ESMO Open ; volume 8, issue 1, page 101382 ; ISSN 2059-7029
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101382Test
https://api.elsevier.com/content/article/PII:S2059702923006087?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702923006087?httpAccept=text/plainTest -
5دورية أكاديمية
المؤلفون: Ribeiro, J.T.M.L.M., Rassy, E., Salabert, L., Viansone, A.A., Parpaleix, A., Blanc, A.S., Mahout, I., Laghouati, S., Mouret Reynier, M.A., Petit, T., André, F., Michiels, S., Dalenc, F., Pistilli, B., Arnedos, M.
المصدر: ESMO Open ; volume 8, issue 1, page 101495 ; ISSN 2059-7029
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101495Test
https://api.elsevier.com/content/article/PII:S2059702923007214?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702923007214?httpAccept=text/plainTest -
6دورية أكاديمية
المؤلفون: Epaillard, N., Lusque, A., Jacot, W., Mailliez, A., Bachelot, T., Arnedos, M., Dieras, V.C., Brain, E.G.C., Ferrero, J-M., Massard, V., Desmoulins, I., Mouret, M-A., Levy, C., Gonçalves, A., Leheurteur, M., Petit, T., Filleron, T., Bosquet, L., Pistilli, B., Frenel, J-S.
المصدر: ESMO Open ; volume 8, issue 1, page 101406 ; ISSN 2059-7029
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101406Test
https://api.elsevier.com/content/article/PII:S2059702923006324?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702923006324?httpAccept=text/plainTest -
7دورية أكاديمية
المؤلفون: Andre, F., Filleron, T., Kamal, M., Mosele, F., Arnedos, M., Dalenc, Florence, Sablin, M. P., Campone, M., Bonnefoi, H., Lefeuvre-Plesse, Claudia, Jacot, William, Coussy, F., Ferrero, J. M., Emile, G., Mouret-Reynier, Marie Ange, Thery, J. C., Isambert, Nicolas, Mege, A., Barthelemy, Philippe, You, B., Hajjaji, Nawale, Lacroix, L., Rouleau, E., Tran-Dien, A., Boyault, S., Attignon, V., Gestraud, Pierre, Servant, N., Le Tourneau, C., Cherif, L. L., Soubeyran, I., Montemurro, F., Morel, A., Lusque, A., Jimenez, M., Jacquet, A., Gonçalves, A., Bachelot, T., Bieche, I.
المساهمون: Université de Lille, Inserm, CHU Lille, Institut Gustave Roussy IGR, Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse U981, Institut Claudius Regaud, Institut Curie - Saint Cloud ICSC, Institut de Cancérologie de l'Ouest Angers/Nantes UNICANCER/ICO, Institut Bergonié Bordeaux, CRLCC Eugène Marquis CRLCC, Institut de Recherche en Cancérologie de Montpellier IRCM - U1194 Inserm - UM, Centre de Lutte contre le Cancer Antoine Lacassagne Nice UNICANCER/CAL, Centre Jean Perrin Clermont-Ferrand UNICANCER/CJP, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Département d'oncologie médicale Centre Georges-François Leclerc, Centre Régional de Lutte contre le cancer Georges-François Leclerc Dijon UNICANCER/CRLCC-CGFL, Institut Sainte Catherine Avignon, Institut de Cancérologie de Strasbourg Europe ICANS, Université Claude Bernard Lyon 1 UCBL, Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192, Centre Léon Bérard Lyon, Mines Paris - PSL (École nationale supérieure des mines de Paris), CRLCC - Centre Paul Papin CRLCC Paul Papin, Institut Cochin IC UM3 (UMR 8104 / U1016), Institut Curie Paris
وصف الملف: application/pdf
العلاقة: Nature; http://hdl.handle.net/20.500.12210/92593Test
-
8دورية أكاديمية
المؤلفون: Geyer, CE, Garber, JE, Gelber, RD, Yothers, G, Taboada, M, Ross, L, Rastogi, P, Cui, K, Arahmani, A, Aktan, G, Armstrong, AC, Arnedos, M, Balmana, J, Bergh, J, Bliss, J, Delaloge, S, Domchek, SM, Eisen, A, Elsafy, F, Fein, LE, Fielding, A, Ford, JM, Friedman, S, Gelmon, KA, Gianni, L, Gnant, M, Hollingsworth, SJ, Im, S-A, Jager, A, Lakhani, SR, Janni, W, Linderholm, B, Liu, T-W, Loman, N, Korde, L, Loibl, S, Lucas, PC, Marme, F, de Duenas, EM, McConnell, R, Phillips, K-A, Piccart, M, Rossi, G, Schmutzler, R, Senkus, E, Shao, Z, Sharma, P, Singer, CF, Spanic, T, Stickeler, E, Toi, M, Traina, TA, Viale, G, Zoppoli, G, Park, YH, Yerushalmi, R, Yang, H, Pang, D, Jung, KH, Mailliez, A, Fan, Z, Tennevet, I, Zhang, J, Nagy, T, Sonke, GS, Sun, Q, Parton, M, Colleoni, MA, Schmidt, M, Brufsky, AM, Razaq, W, Kaufman, B, Cameron, D, Campbell, C, Tutt, ANJ, Johannsson, OT
العلاقة: pii: S0923-7534(22)04165-5; Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmana, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F. ,. Johannsson, O. T. (2022). Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1 / 2 and high-risk, early breast cancer. ANNALS OF ONCOLOGY, 33 (12), pp.1250-1268. https://doi.org/10.1016/j.annonc.2022.09.159Test.; http://hdl.handle.net/11343/335010Test
-
9دورية أكاديمية
المؤلفون: Palafox, M, Monserrat, L, Bellet, M, Villacampa, G, Gonzalez-Perez, A, Oliveira, M, Brasó-Maristany, F, Ibrahimi, N, Kannan, S, Mina, L, Herrera-Abreu, MT, Òdena, A, Sánchez-Guixé, M, Capelán, M, Azaro, A, Bruna, A, Rodríguez, O, Guzmán, M, Grueso, J, Viaplana, C, Hernández, J, Su, F, Lin, K, Clarke, RB, Caldas, C, Arribas, J, Michiels, S, García-Sanz, A, Turner, NC, Prat, A, Nuciforo, P, Dienstmann, R, Verma, CS, Lopez-Bigas, N, Scaltriti, M, Arnedos, M, Saura, C, Serra, V
المساهمون: Bruna Cabot, Alejandra, Turner, Nicholas
مصطلحات موضوعية: Antineoplastic Agents, Biomarkers, Breast Neoplasms, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Drug Resistance, Neoplasm, Female, Humans, Phosphatidylinositol 3-Kinases, Protein Kinase Inhibitors, Receptors, Estrogen, Retinoblastoma Binding Proteins, Ubiquitin-Protein Ligases
جغرافية الموضوع: England
وصف الملف: Electronic; application/pdf
العلاقة: ARTN 5258; Nature Communications, 2022, 13 (1), pp. 5258 -; https://repository.icr.ac.uk/handle/internal/5606Test
الإتاحة: https://doi.org/10.1038/s41467-022-32828-6Test
https://repository.icr.ac.uk/handle/internal/5606Test -
10دورية أكاديمية
المؤلفون: Blaye, C., Darbo, É., Debled, M., Brouste, V., Vélasco, V., Pinard, C., Larmonier, N., Pellegrin, I., Tarricone, A., Arnedos, M., Commeny, J., Bonnefoi, H., Larmonier, C., MacGrogan, G.
المصدر: ESMO Open ; volume 7, issue 4, page 100502 ; ISSN 2059-7029
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100502Test
https://api.elsevier.com/content/article/PII:S2059702922001223?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702922001223?httpAccept=text/plainTest
النص الكامل